When it comes to a successful glaucoma intervention, SEEING IS BELIEVING. Only ViaLase® offers a truly noninvasive solution that combines femtosecond laser precision and the accuracy of micron-level image guidance in one revolutionary glaucoma treatment.
With a leadership team that has vast experience developing and commercializing the first femtosecond lasers for ophthalmic surgery; ViaLase is now bringing that expertise and innovation to glaucoma patients.
The ViaLuxe™ Laser System creates a precise, customized drainage channel through the trabecular meshwork at the iridocorneal angle — increasing aqueous outflow without opening up the eye.
The patient is docked to the laser system via the proprietary ViaLens™ patient interface and secured via vacuum suction, giving the surgeon control of the patient's eye, head and body movement.
Proprietary gonioscopic capabilities display real-time, high-resolution video of the iridocorneal angle, allowing the surgeon to inspect the angle and select the desired treatment location.
The specialized optical delivery system is designed to deliver tightly focused femtosecond laser pulses through the cornea and into the iridocorneal angle while minimizing damage to adjacent tissue.
During treatment, a single channel that is 500 μm in width and 200 μm high is created through the trabecular meshwork, thus treating just 5 degrees of the angle.
Following creation of the drainage channel, OCT imaging allows the user to visualize sub-surface tissue structures relative to the location of the channel and document those imaging findings.
Study Design:
The 24-month prospective, non-randomized, single-center, interventional, single-arm trial evaluated 17 eyes with open angle glaucoma following FLigHT treatment, which consisted of the creation of a single channel through the trabecular meshwork and into Schlemm's canal.
Reference:
Nagy Z.Z., Kranitz K., Ahmed I.I.K., De Francesco T., Mikula E. & Juhasz T., First-in-Human Safety Study of Femtosecond Laser Image-Guided Trabeculotomy for Glaucoma Treatment, Ophthalmology Science, Volume 3, Issue 4, 100313, December 2023 Page 1: Efficacy and Safety Data
Well defined channels clearly visible at 24 months by proprietary on-board ViaVue™ gonioscopic camera and anterior segment OCT, with no evidence of closure or scarring.
Disclaimer:
Channel is validated by third-party OCT
Reference:
Nagy Z.Z., Kranitz K., Ahmed I.I.K., De Francesco T., Mikula E. & Juhasz T., First-in-Human Safety Study of Femtosecond Laser Image-Guided Trabeculotomy for Glaucoma Treatment, Ophthalmology Science, Volume 3, Issue 4, 100313, December 2023 Page 1: Efficacy and Safety Data
